Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients.
about
Interventions to improve adherence to lipid lowering medicationInterventions to improve adherence to lipid lowering medicationTaking simvastatin in the morning compared with in the evening: randomised controlled trialThe association of patient trust and self-care among patients with diabetes mellitusStatin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.Improving medication adherence in hypercholesterolemia: challenges and solutions.Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testingAchievement of cardiovascular risk factor targets in young adults with diabetes mellitus.Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis.Lessons from france: the cardiovascular prevention clinic in the la pitié-salpêtrière hospital in paris.Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease.Adherence to pharmacotherapy in patients with alcohol and opioid dependence.Factors of compliance in patients with hypercholesterolemia using rosuvastatin in primary care.Adherence to lipid-lowering treatment: the patient perspective.Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western AustraliaThe significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.Family practice patients' adherence to statin medications.Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?Factors affecting therapeutic compliance: A review from the patient's perspective.Effects of single-dose morning and evening administration of pravastatin on antioxidant markers in cholesterol-fed rabbitsManagement of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.Factors associated with medical orders' compliance among hyperlipidemic patientsImpact of adherence to statins on chronic heart failure in primary prevention.Patients' Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study.Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?Adherence with medications used to treat osteoporosis: behavioral insights.Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs.Adherence to Psychiatric Follow-up Predicts 1-Year BMI Loss in Gastric Bypass Surgery Patients.Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results.Treatment beliefs and attending follow-up visits in a lipid clinic.Serum uric acid levels: a useful but not absolute marker of compliance with fenofibrate treatment.Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients.Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication.Development and Application of the Lincoln Adherence Instrument Record for Assessing Client Adherence to Advice in Dog Behavior Consultations and Success.
P2860
Q24236817-0B449183-D3EB-4616-9908-CB530AC541F7Q24245739-B87D6E48-C1D5-4A09-A9B9-8F44DC3BD1A7Q24677046-C33ADF36-29C8-4A28-BD79-955D3BCF9022Q24802351-49348572-200D-4D24-8E56-D75345609D6FQ33900403-5A549233-1B83-4F61-AB2A-FA6F0F91D72BQ34482456-7BF77A31-76DC-4105-8FAC-53CCBAD3100BQ34608646-DF97B2E9-5654-4879-8893-776D3D0DC0C5Q34620412-8FDE0D53-5593-4EB8-B99D-CC6525C79F69Q35694196-20FB82CE-8C9A-4CC1-AE30-1DE900D21C55Q35741915-9BAD62F5-010A-49C3-A665-4E70B236133BQ35826483-753FA0DA-9C4C-42CB-AAB3-35ED2F7479E4Q35925788-100D2093-110C-4AA4-8133-B96413A533ABQ36346866-DD13DE07-F2DE-4E13-81D0-4EC89D1B4D58Q36394334-64CF792B-6CCC-4C8E-A02F-F130A5834706Q36411739-8C81D69B-5A8D-41B0-87DE-35676F1BE366Q36432150-791036CB-45A1-4696-9939-ACD026C8F95DQ36440488-37208F02-6384-4AE4-A77D-601181496769Q36704251-BD1B0ADE-105B-4B4B-A92F-B8BC87C4E838Q36822915-3D22ECF6-9407-47D8-90BA-517B3B43D78AQ36890472-17B0BCC2-4C24-4246-8F31-CADF059DA3ABQ36906018-8BE9941F-275E-4FA1-A757-CD726AE77F78Q37108172-8E0CAC2E-D8B5-41A9-A53E-19FBA6C09307Q37142460-787E018B-A845-40C5-9E74-B80D9EB0CA95Q37321883-419E8A8D-4D38-4DCF-A847-E57C0378180AQ37423691-19326A12-AB40-4259-B0CD-8ABAA7C8C1F7Q38075457-3D3E8987-2AAB-4600-B8DE-C530FC7824F9Q40100271-2F74F952-A4F0-42FB-A567-CAE269A5EBE6Q40699550-3B1A2706-7157-4BDE-BCBD-0ABAA0A067EEQ41189959-5EDEEC39-ECED-467D-8778-D2806C18AF33Q43418044-1E88490F-88DC-4AC6-A71D-0658BF6A1869Q43830924-AF829099-C84D-4300-B713-25808B2EFF08Q43892677-FC62B5A7-A2EB-4BFB-9F65-610EDFF703B6Q43948677-1D8A37B1-3AB5-42B7-95A3-40B7979F56F0Q44236160-5F3568E0-4E2A-4FD0-8FDE-035EA35CECE1Q50989752-F169AB19-327C-479B-A87F-D3B38735A3E6Q53429731-C64F0636-AE96-40B8-B306-9B9234A98173
P2860
Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Factors associated with low co ...... gs in hyperlipidemic patients.
@en
type
label
Factors associated with low co ...... gs in hyperlipidemic patients.
@en
prefLabel
Factors associated with low co ...... gs in hyperlipidemic patients.
@en
P2093
P2860
P1476
Factors associated with low co ...... gs in hyperlipidemic patients.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2710.2000.00315.X
P577
2000-12-01T00:00:00Z